• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用去糖基化修饰血凝素进行疫苗接种可广泛保护小鼠和雪貂免受流感病毒感染。

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets.

作者信息

Zhang Limin, Chen Junyu, Shen Chenguang, Wang Guosong, Lu Zhen, Zeng Dian, Gao Ying, Chen Huiqing, Xia Ningshao, Chen Yixin

机构信息

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen 361102, China.

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China.

出版信息

Vaccines (Basel). 2022 Aug 11;10(8):1304. doi: 10.3390/vaccines10081304.

DOI:10.3390/vaccines10081304
PMID:36016191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9414581/
Abstract

Recent efforts have been directed toward the development of universal influenza vaccines inducing broadly neutralizing antibodies to conserved antigenic supersites of Hemagglutinin (HA). Although several studies raise the importance of glycosylation in HA antigen design, whether this theory can be widely confirmed remains unclear; which influenza HA with an altered glycosylation profile could impact the amplitude and focus of the host immune response. Here, we evaluated the characteristics and efficacy of deglycosylated modified HA proteins, including monoglycosylated HA (HA), unglycosylated HA (HA), and fully glycosylated HA (HA), without treatment with H3N2 Wisconsin/67/2005. Our results showed that HA could induce a cross-strain protective immune response in mice against both H3N2 and H7N9 subtypes with better antibody-dependent cellular cytotoxicity (ADCC) than the HA- and HA-immunized groups, which suggested that highly conserved epitopes that were masked by surface glycosylation may be exposed and thus promote the induction of broad antibodies that recognize the hidden epitopes. This strategy may also supplement the direction of deglycosylated modified HA for universal influenza vaccines.

摘要

近期的研究致力于开发通用流感疫苗,该疫苗可诱导产生针对血凝素(HA)保守抗原超位点的广泛中和抗体。尽管多项研究凸显了糖基化在HA抗原设计中的重要性,但这一理论能否得到广泛证实仍不明确;改变糖基化谱的哪种流感HA会影响宿主免疫反应的强度和靶向性。在此,我们评估了去糖基化修饰的HA蛋白的特性和功效,包括单糖基化HA(HA)、无糖基化HA(HA)和完全糖基化HA(HA),未用H3N2威斯康星/67/2005进行处理。我们的结果表明,HA能在小鼠体内诱导针对H3N2和H7N9亚型的跨毒株保护性免疫反应,其抗体依赖性细胞毒性(ADCC)比HA免疫组和HA免疫组更好,这表明被表面糖基化掩盖的高度保守表位可能会暴露出来,从而促进诱导识别隐藏表位的广谱抗体。该策略也可为通用流感疫苗的去糖基化修饰HA方向提供补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/ec391281c410/vaccines-10-01304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/02503ace0732/vaccines-10-01304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/ec99f7c60c5a/vaccines-10-01304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/2b5caa2622f5/vaccines-10-01304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/ec391281c410/vaccines-10-01304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/02503ace0732/vaccines-10-01304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/ec99f7c60c5a/vaccines-10-01304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/2b5caa2622f5/vaccines-10-01304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e6/9414581/ec391281c410/vaccines-10-01304-g004.jpg

相似文献

1
Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets.用去糖基化修饰血凝素进行疫苗接种可广泛保护小鼠和雪貂免受流感病毒感染。
Vaccines (Basel). 2022 Aug 11;10(8):1304. doi: 10.3390/vaccines10081304.
2
Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.单糖基化血凝素疫苗接种可诱导针对流感病毒感染的跨株保护。
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2476-81. doi: 10.1073/pnas.1323954111. Epub 2014 Jan 27.
3
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.在对历史 H3N2 流感病毒无预存免疫的雪貂中引发针对未来 20 年 H3N2 共循环流感病毒变异株的保护性抗体。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.00946-18. Print 2019 Feb 1.
4
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
5
Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.以鸡蛋为基础的单糖基化流感裂病毒疫苗可诱导针对流感病毒感染的跨株保护。
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4200-4205. doi: 10.1073/pnas.1819197116. Epub 2019 Feb 19.
6
Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs.免疫接种三重 H5N1/NA-HA-M1 VLP 后对产生通用抗 HA-茎部抗体的免疫反应进行表征。
Viruses. 2022 Mar 30;14(4):730. doi: 10.3390/v14040730.
7
Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.鉴定 H7N9 血凝素新型蛋白表位,这些表位能够引发强烈的抗体依赖的、细胞介导的细胞毒性活性,并能在小鼠模型中预防流感感染。
Cell Immunol. 2021 Jan;359:104255. doi: 10.1016/j.cellimm.2020.104255. Epub 2020 Dec 6.
8
Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.在有既往流感感染史的动物中诱导广谱中和流感抗体。
Sci Transl Med. 2012 Aug 15;4(147):147ra114. doi: 10.1126/scitranslmed.3004273.
9
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.含Matrix-M™佐剂的新型血凝素纳米颗粒流感疫苗在雪貂体内诱导产生针对同源和变异的A(H3N2)亚型的血凝抑制、中和及保护性反应。
Vaccine. 2017 Sep 25;35(40):5366-5372. doi: 10.1016/j.vaccine.2017.08.021. Epub 2017 Aug 22.
10
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells.一种非中和抗体通过与效应细胞相互作用广泛保护机体免受流感病毒感染。
PLoS Pathog. 2021 Aug 5;17(8):e1009724. doi: 10.1371/journal.ppat.1009724. eCollection 2021 Aug.

引用本文的文献

1
A Recombinant Mosaic HAs Influenza Vaccine Elicits Broad-Spectrum Immune Response and Protection of Influenza a Viruses.一种重组嵌合血凝素流感疫苗可引发广谱免疫反应并对甲型流感病毒起到保护作用。
Vaccines (Basel). 2024 Sep 2;12(9):1008. doi: 10.3390/vaccines12091008.
2
Very Broadly Effective Hemagglutinin-Directed Influenza Vaccines with Anti-Herpetic Activity.具有抗疱疹活性的广谱高效血凝素导向流感疫苗。
Vaccines (Basel). 2024 May 14;12(5):537. doi: 10.3390/vaccines12050537.
3
The Development of a Rabies Virus-Vectored Vaccine against , Targeting BBI39.

本文引用的文献

1
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.一种基于减毒活病毒的鼻内新型冠状病毒肺炎疫苗能对严重急性呼吸综合征冠状病毒2提供快速、持久且广泛的保护。
Sci Bull (Beijing). 2022 Jul 15;67(13):1372-1387. doi: 10.1016/j.scib.2022.05.018. Epub 2022 May 26.
2
Effectiveness of maternal vaccination with quadrivalent inactivated influenza vaccine in pregnant women and their infants in 2019-2020.2019-2020 年四价灭活流感疫苗对孕妇及其婴儿的有效性。
Expert Rev Vaccines. 2022 Jul;21(7):983-992. doi: 10.1080/14760584.2022.2013820. Epub 2022 Jan 24.
3
一种针对BBI39的狂犬病病毒载体疫苗的研发
Vaccines (Basel). 2024 Jan 12;12(1):78. doi: 10.3390/vaccines12010078.
4
Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).针对冠状病毒变体的低糖通用 mRNA 疫苗,该疫苗在 SARS-CoV-2 刺突信使 RNA(mRNA)的 S2 或茎中删除了糖基化位点。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2314392120. doi: 10.1073/pnas.2314392120. Epub 2023 Nov 27.
Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization.
通过高糖基化和二硫键稳定来改变血凝素免疫原的免疫原性。
Front Immunol. 2021 Oct 7;12:737973. doi: 10.3389/fimmu.2021.737973. eCollection 2021.
4
Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models.大环肽对流感病毒 HA 表现出抗病毒作用,并能预防动物模型中的肺炎。
Nat Commun. 2021 May 11;12(1):2654. doi: 10.1038/s41467-021-22964-w.
5
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020.美国 2019-2020 年流感疫苗效力受抗原漂移影响的研究
Clin Infect Dis. 2021 Dec 6;73(11):e4244-e4250. doi: 10.1093/cid/ciaa1884.
6
Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure.流感血凝素的结构生物学:一场永恒的冒险。
Viruses. 2020 Sep 22;12(9):1053. doi: 10.3390/v12091053.
7
Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility.利用动物模型评估奥司他韦对体外敏感性降低的甲型和乙型流感病毒的疗效。
PLoS Pathog. 2020 Jun 18;16(6):e1008592. doi: 10.1371/journal.ppat.1008592. eCollection 2020 Jun.
8
FcγR Binding and ADCC Activity of Human IgG Allotypes.人 IgG 同种异型的 FcγR 结合和 ADCC 活性。
Front Immunol. 2020 May 6;11:740. doi: 10.3389/fimmu.2020.00740. eCollection 2020.
9
Glycosylation as a tool for rational vaccine design.糖基化作为一种合理疫苗设计的工具。
Biotechnol Bioeng. 2020 Aug;117(8):2556-2570. doi: 10.1002/bit.27361. Epub 2020 May 13.
10
Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.分析疫苗诱导的流感 B 病毒血凝素特异性抗体依赖的细胞细胞毒性反应。
Virus Res. 2020 Feb;277:197839. doi: 10.1016/j.virusres.2019.197839. Epub 2019 Dec 16.